Clinical trial
NY-ESO-1 TCR （TAEST16001）for Patients With Advanced NSCLC
NCT03029273
Study timeline
Study start (actual)2017-03-21Date precision: day
Registry last updated2019-01-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancer, Nonsmall Cell, Recurrentunresolved
Interventions
Sponsors & collaborators
Guangzhou Institute of Respiratory Diseaselead sponsor
Xiangxue Life Science Research Centercollaborator
Xiangxue Pharmaceuticalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03029273 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.